FG-LPXC-LUNG

N/A

Report date: 2025/06/11 10:49:06
NME

Base Information

Drug NameFG-LPXC-LUNG
Drug Alias NameLpxC inhibitor (Blacksmith Medicines)
ClassificationSmall molecules
Mechanisms of ActionAntibacterial multidrug resistance inhibitorsUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlacksmith Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding LtdBlacksmith Medicines Inc
Inactive CompaniesN/A
Active IndicationsPneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A